Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.840
0.00 (0.00%)
At close: Jun 9, 2026, 4:00 PM EDT
1.890
+0.050 (2.72%)
After-hours: Jun 9, 2026, 7:13 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $182.49 million as of June 9, 2026. Its market cap has increased by 92.37% in one year.
Market Cap
182.49M
Enterprise Value
90.81M
1-Year Change
92.37%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $182.49M, a decrease of -79.46%. That is a compound annual growth rate of -27.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 182.49M | 22.80% |
| Dec 31, 2025 | 148.61M | 3.22% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
| Jul 23, 2021 | 888.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compugen | 192.95M |
| Karyopharm Therapeutics | 191.69M |
| Tonix Pharmaceuticals Holding | 186.67M |
| MediWound | 182.63M |
| Alector | 182.08M |
| NovaBridge Biosciences | 180.41M |
| Unicycive Therapeutics | 177.82M |
| OnKure Therapeutics | 177.74M |